<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Combination of laparoscopic ileal interposition (II) with sleeve gastrectomy (SG) is an upcoming procedure, which offers good metabolic improvement and weight reduction without causing significant <z:hpo ids='HP_0002024'>malabsorption</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of this study was to evaluate the results of this novel procedure for control of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and related <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: The II and SG was performed in 43 patients (M:F = 25:18) from February 2008 </plain></SENT>
<SENT sid="3" pm="."><plain>Participants had a mean age of 47.2 ± 8.2 years (range 29-66 years), mean duration of <z:mp ids='MP_0002055'>diabetes</z:mp> of 10.1 ± 9.2 years (range 1-32 years), and mean preoperative body mass index (BMI) of 33.2 ± 7.8 kg/m2 </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had poorly controlled type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) [mean glycated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (HbA1C) 9.6 ± 2.1%] despite use of oral <z:chebi fb="0" ids="35526">hypoglycemic agents</z:chebi> (OHAs) and/or insulin </plain></SENT>
<SENT sid="5" pm="."><plain>Thirty (70%) patients had <z:hpo ids='HP_0000822'>hypertension</z:hpo>, 20 (46%) had <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, and 18 (42%) had significant <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The primary outcome was remission of <z:mp ids='MP_0002055'>diabetes</z:mp> (HbA1C &lt; 6.5% without OHAs/insulin) and the secondary outcomes were reduction in <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> agent requirement and components of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Mean follow-up was for 20.2 ± 8.6 months (range 4-40 months) </plain></SENT>
<SENT sid="8" pm="."><plain>Postoperatively, glycemic parameters (fasting and post-lunch blood sugar, HbA1C improved in <z:hpo ids='HP_0000001'>all</z:hpo> patients (P &lt; 0.05) at <z:hpo ids='HP_0000001'>all</z:hpo> intervals </plain></SENT>
<SENT sid="9" pm="."><plain>Twenty (47%) patients had remission in <z:mp ids='MP_0002055'>diabetes</z:mp> and the remaining patients showed significantly decreased OHA requirement </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had <z:hpo ids='HP_0001824'>weight loss</z:hpo> between 15 and 30% (P &lt; 0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>Twenty-seven (90%) patients had remission in <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>At 3 years, the mean fall in HbA1C (34%) was more than reduction in BMI (25%) </plain></SENT>
<SENT sid="13" pm="."><plain>There was a declining trend in <z:chebi fb="23" ids="18059">lipids</z:chebi> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> postoperatively, though it was significant for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> only </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: The laparoscopic II with SG seems to be a promising procedure for control of type 2 DM, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, weight reduction, and associated <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> </plain></SENT>
<SENT sid="15" pm="."><plain>A multicenter study with larger number of patients and a longer follow-up period is needed to substantiate our preliminary findings </plain></SENT>
</text></document>